5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside (AICA-riboside) as a Targeting Agent for Therapy of Patients With Acute Lymphoblastic Leukemia: Are We There and Are There Pitfalls?
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Oncology,Hematology,Pediatrics, Perinatology, and Child Health
Reference28 articles.
1. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy;Sengupta;Mol Cancer,2007
2. Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside;Beckers;Mol Cancer Ther,2006
3. 5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells;Sabina;J Biol Chem,1985
4. Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate;Allegra;J Biol Chem,1987
5. The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation;Cronstein;J Clin Invest,1993
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis of Modified C-Nucleosides of Therapeutic Significant: A Succinct Account;Synlett;2023-11-02
2. AICAR Improves Outcomes of Metabolic Syndrome and Type 2 Diabetes Induced by High-Fat Diet in C57Bl/6 Male Mice;International Journal of Molecular Sciences;2022-12-11
3. Applications of Purine Ring Opening in the Synthesis of Imidazole, Pyrimidine, and New Purine Derivatives;European Journal of Organic Chemistry;2021-08-26
4. Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models;Scientific Reports;2018-10-18
5. Synthesis of double-13C-labeled imidazole derivatives;Tetrahedron Letters;2018-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3